HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Early rituximab therapy offers option for treating asymptomatic follicular lymphoma
-
- FDA warns of accidental overdose with morphine sulfate oral solution
- Iniparib may improve benefits of gemcitabine-carboplatin in triple-negative breast cancer
- Prior discussion of end-of-life measures shortened decision time for caregivers of critically ill patients
- Neuroendocrine ductal carcinoma of the breast Ramya Varadarajan, MD
- A classic presentation of endolymphatic sac tumor Munir Ghesani, MD, FACNM; Daniel E. Meltzer, MD
- Amplicon fusion site polymerase chain reaction effectively detected cancer cells
- Cerebrospinal fluid microRNAs may aid primary CNS lymphoma diagnosis
- Doppler screening, intensification therapy reduced risk for stroke associated with sickle cell anemia
-
- High-risk HPV related to oropharyngeal squamous cell carcinomas in nonsmoking, nondrinking patients
- Medical imaging may be unnecessary in CLL staging, follow-up
- One-fifth of survivors reported cancer-related chronic pain
- Restoration of NFKBIA gene inhibited tumor growth, increased chemosensitivity in glioblastoma multiforme
- Surgical resection may aid chemotherapy in DLBCL treatment
- FDG-PET identified early response to chemotherapy in rare esophageal cancer
- IMRT produced less toxicity, similar outcomes as conventional radiation in anal cancer
- Sorafenib viable option in treating drug-resistant GIST
-
- SWOG 0356: High gene-expression ERCC1 levels predicted poorer survival
- Management strategies for inoperable malignant bowel obstruction Stephanie M. Harman, MD, FACP